Invention Grant
- Patent Title: Factor IX fusion proteins and methods of making and using same
-
Application No.: US15750119Application Date: 2016-08-03
-
Publication No.: US10745680B2Publication Date: 2020-08-18
- Inventor: Zhiqian Liu , Arjan Van Der Flier , David R. Light , Ekta Seth Chhabra , Tongyao Liu , Robert T. Peters , John Kulman , Ayman Ismail
- Applicant: Bioverativ Therapeutics Inc.
- Applicant Address: US MA Waltham
- Assignee: Bioverativ Therapeutics Inc.
- Current Assignee: Bioverativ Therapeutics Inc.
- Current Assignee Address: US MA Waltham
- Agency: Lathrop GPM LLP
- Agent James H. Velema, Esq.
- International Application: PCT/US2016/045401 WO 20160803
- International Announcement: WO2017/024060 WO 20170209
- Main IPC: C12N9/64
- IPC: C12N9/64 ; C07K14/745 ; A61K9/00 ; A61P7/04 ; C07K14/00 ; A61K38/00
Abstract:
The present invention provides Factor IX (FIX) fusion proteins comprising at least one heterologous moiety, such as an XTEN. The present invention further discloses methods of making and using the FIX fusion proteins.
Public/Granted literature
- US20180355341A1 FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME Public/Granted day:2018-12-13
Information query
IPC分类:
